437 results on '"Mancardi, Giovanni"'
Search Results
2. Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study
3. Resting‐state functional connectivity and motor imagery brain activation
4. Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis
5. Erythropoietin therapy in a case of neonatal anemia after exposure to natalizumab throughout pregnancy
6. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
7. Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study
8. Recapitulation of B Cell Differentiation in the Central Nervous System of Patients with Multiple Sclerosis
9. How people with multiple sclerosis cope with a sustained finger motor task: A behavioural and fMRI study
10. Different MRI patterns in MS worsening after stopping fingolimod
11. Chapter 11 - Hematopoietic stem cell transplantation for multiple sclerosis
12. Chapter 1 - Introduction to HSCT for neurologic diseases
13. Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis
14. How much do periventricular lesions assist in distinguishing migraine with aura from CIS?
15. Delirium in the acute phase after stroke: comparison between methods of detection
16. Aging with multiple sclerosis: Clinical characterization of an elderly population, a cross-sectional study
17. Evaluation of IAUGC indices and two DCE-MRI pharmacokinetic parameters assessed by two different theoretical algorithms in patients with brain tumors
18. Selective impairments of motor sequence learning in multiple sclerosis patients with minimal disability
19. Upper limb motor rehabilitation impacts white matter microstructure in multiple sclerosis
20. Dramatic rebounds of MS during pregnancy following fingolimod withdrawal
21. Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy
22. Cord cross-sectional area at foramen magnum as a correlate of disability in amyotrophic lateral sclerosis
23. Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis
24. Basal ganglia are active during motor performance recovery after a demanding motor task
25. Cell-based therapeutic strategies for multiple sclerosis
26. Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS
27. Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis
28. Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients
29. Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study
30. Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study
31. The spectrum of GNE mutations: allelic heterogeneity for a common phenotype
32. COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy
33. Growing Region Segmentation Software (GRES) for quantitative magnetic resonance imaging of multiple sclerosis: intra- and inter-observer agreement variability: a comparison with manual contouring method
34. Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis
35. Human mesenchymal stem cells modulate B-cell functions
36. Structural integrity of callosal midbody influences intermanual transfer in a motor reaction-time task
37. Autologous hematopoietic stem cell transplantation versus alemtuzumab in aggressive MS: a retrospective real-word study (4096)
38. Tailoring B-cells depleting therapy in MS according to memory B-cells monitoring: a pilot study (2159)
39. Frontal Networks Play a Role in Fatigue Perception in Multiple Sclerosis
40. Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter
41. A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis
42. B-cell differentiation in the CNS of patients with multiple sclerosis
43. SI_nonumbers – Supplemental material for Position Sense Deficits at the Lower Limbs in Early Multiple Sclerosis: Clinical and Neural Correlates
44. The Italian Natalizumab Registry: A 1-Year Follow-Up: 072.
45. RITUXIMAB EFFICACY IN CIDP ASSOCIATED WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
46. Carcinoma of the tongue mimicking bulbar amyotrophic lateral sclerosis
47. Relapses After Treatment With Rituximab in a Patient With Multiple Sclerosis and Anti–Myelin-Associated Glycoprotein Polyneuropathy
48. Altered Glutamate Reuptake in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Cortex: Correlation With Microglia Infiltration, Demyelination, and Neuronal and Synaptic Damage
49. Predictors of response to rituximab in patients with neuropathy and anti–myelin associated glycoprotein immunoglobulin M
50. Symptomatic therapy in multiple sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.